U.S. pharma huge copyright scrapped two experimental weight loss capsules previous 12 months—a when-everyday pill, lotiglipron, because of elevated liver enzymes and a 2 times-every day pill, danuglipron, on account of potent side effects—but CEO Albert Bourla has explained the compa